Investment Rating - The report assigns an IPO-specific rating of 6.3 to the company, based on various criteria including operational performance, industry outlook, valuation, and market sentiment [6]. Core Insights - Haitai Foods is recognized as a leading player in the Chinese condiment market, holding the position of the largest condiment company in China and the fifth largest globally, with a diverse product range including soy sauce, oyster sauce, and specialty condiments [1][2]. - The company has demonstrated resilience with projected revenues of 245 billion RMB for 2023, 269 billion RMB for 2024, and 83 billion RMB for Q1 2025, alongside net profits of 56.3 billion RMB, 63.4 billion RMB, and 22 billion RMB respectively, indicating a recovery trend after a challenging 2023 [1]. - The Chinese condiment market is expected to grow from 408.1 billion RMB in 2019 to 498.1 billion RMB in 2024, with a compound annual growth rate (CAGR) of 4.1%, driven by rising disposable incomes and urbanization [2]. Company Overview - Haitai Foods has cultivated a strong brand presence with multiple flagship products and a comprehensive distribution network, covering nearly 100% of prefecture-level cities and about 90% of county-level cities in China [3]. - The company has launched over 1,450 SKUs to meet the diverse needs of restaurants, food processing enterprises, and end consumers, showcasing a well-rounded product matrix [1][3]. - As of March 2025, the company's debt-to-asset ratio stands at 16%, and the return on equity (ROE) for 2024 is projected at 21% [1]. Industry Status and Outlook - The condiment industry in China is characterized by a fragmented competitive landscape, with Haitai Foods holding a market share of 4.8% domestically, leading the sector [2]. - The global condiment market is valued at approximately 21,438 billion RMB, with a growth rate of about 3.2% [2]. - The increasing trend of restaurant chain development and the fast-paced lifestyle of consumers are expected to further boost the demand for diverse condiments in China [2]. Investment Considerations - The report highlights a strong lineup of cornerstone investors for the IPO, including notable firms such as Hillhouse, GIC, and UBS Asset Management, which collectively account for approximately 48.8%-50.66% of the offering [5]. - The IPO price range is set between 35-36.3 HKD, with a post-IPO market capitalization estimated at 9.2-9.5 billion HKD, indicating an attractive valuation compared to the latest A-share prices, which are at a discount of about 20%-23% [5][6].

Investment Rating - The investment rating for the company is "6.3" based on various criteria [6]. Core Insights - Haidilao is a leading player in the Chinese condiment market, holding the position of the largest condiment company in China and the fifth largest globally, with a diverse product range including soy sauce, oyster sauce, and other seasonings [1][2]. - The company has shown a revenue forecast of 245 billion RMB for 2023, 269 billion RMB for 2024, and 83 billion RMB for Q1 2025, with growth rates of -3.3%, 10.4%, and 9% respectively [1]. - The company has a strong market presence with a 4.8% market share in China's condiment market and a 13.2% share in the soy sauce market [2]. Company Overview - Haidilao has developed a comprehensive product matrix with over 1,450 SKUs and has cultivated seven product lines each generating over 1 billion RMB in revenue [1]. - The company has a robust distribution network with 6,707 distributors, covering nearly 100% of prefecture-level cities and about 90% of county-level cities in China [3]. - The company is focused on both domestic and international markets, with plans to expand globally [1]. Industry Status and Outlook - The Chinese condiment market is projected to grow from 408.1 billion RMB in 2019 to 498.1 billion RMB in 2024, with a compound annual growth rate (CAGR) of 4.1% [2]. - The global condiment market is valued at approximately 21,438 billion RMB, with a growth rate of about 3.2% [2]. - The competitive landscape in the condiment industry is fragmented, with Haidilao leading the market in China [2]. Advantages and Opportunities - The company benefits from strong brand recognition and a leading position in the industry, supported by a well-optimized supply chain that enhances production efficiency and reduces costs [3]. - The company's corporate culture emphasizes simplicity, practicality, and openness, which supports long-term sustainable development [3]. Investment Recommendations - The cornerstone investors for the IPO include prominent firms such as Hillhouse, GIC, and UBS Asset Management, accounting for approximately 48.8%-50.66% of the offering [5]. - The IPO price range is set between 35-36.3 HKD, with a post-IPO market capitalization estimated at 9.2-9.5 billion HKD [5]. - The expected net profit for 2025 is around 7 billion RMB, corresponding to a price-to-earnings (PE) ratio of 29-30x, indicating a reasonable valuation compared to the A-share market [5].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 95, representing a potential upside of 17% from the current price of HKD 81.1 [2][9][10] Core Insights - The report highlights positive updates on IBI363 and IBI343, with IBI363 showing an extended median progression-free survival (mPFS) of 9.3 months in the 3 mg/kg dose group for IO-treated squamous non-small cell lung cancer (sq-NSCLC), enhancing confidence in its development for lung squamous carcinoma [1][7][10] - The company is expected to initiate Phase 3 registration clinical trials for IBI363 in the 3L+ sq-NSCLC setting, with the 3 mg/kg dose likely to be used [7][10] - Financial projections indicate a significant increase in revenue and net profit over the next few years, with expected revenues of RMB 11.7 billion in 2025 and a net profit of RMB 433 million [9][10] Financial Projections - Revenue is projected to grow from RMB 6.2 billion in 2023 to RMB 15.8 billion by 2027, with a compound annual growth rate (CAGR) of 36.2% [9][10] - The adjusted net profit is expected to turn positive in 2025, reaching RMB 1.03 billion by 2025 and RMB 2.66 billion by 2027 [9][10] - The report anticipates peak sales for IBI363 in China to reach approximately RMB 2.5 billion and for IBI343 to reach around RMB 1.5 billion, both on a risk-adjusted basis [10]

Investment Rating - The report maintains a "Buy" rating for Hansoh Pharmaceutical (03692) despite a year-to-date stock price increase of 53% [1] Core Insights - UBS believes that the stock price of Hansoh Pharmaceutical is still undervalued, raising the target price from HKD 24 to HKD 33.3 [1] - The positive outlook is driven by the company's R&D capabilities and revenue potential from collaboration projects, particularly the licensing agreements for BD HS-20094 and HS-10535 [1] - Earnings per share forecasts for Hansoh Pharmaceutical have been increased by 16.2%, 17.7%, and 21.3% for the years 2025 to 2027, with revenue forecasts adjusted upward by 6% to 12% [1] - The main growth drivers are expected to be Aumolertinib and BD, with projected sales for Aumolertinib reaching RMB 6 billion this year and potentially exceeding RMB 8 billion by 2029 [1]

Investment Rating - The investment rating for Pop Mart (09992) is upgraded to "Overweight" by Morgan Stanley [1] Core Insights - Morgan Stanley has raised the target price for Pop Mart from HKD 224 to HKD 302, reflecting a 35% increase [1] - The report emphasizes that Pop Mart's diverse intellectual property and operational capabilities will drive sustainable growth [1] - Although the growth momentum for 2025 may be fully reflected, the long-term growth potential remains underappreciated [1] - Earnings per share forecasts for 2025, 2026, and 2027 have been increased by 6%, 15%, and 21% respectively, indicating a clearer growth path in North America and Europe [1]

Investment Rating - The report maintains a "Buy" rating for China Resources Beer (00291) with a target price of HKD 34 [1] Core Insights - China Resources Beer achieved positive sales growth in April and May, consistent with the sales trend from January to May 2025, benefiting from favorable raw material factors that helped increase gross margin by over 1 percentage point [1] - The company is implementing "Three Precision" initiatives to further reduce operating costs [1] - The management anticipates pressure on the white liquor business revenue this year due to weak demand and high base effects, aiming to avoid losses and impairments [1] Sales Performance by Product - Heineken continues to perform strongly with sales growth exceeding 20% year-on-year - Super X's year-to-date sales have increased by approximately 10% year-on-year - Sales of Old Snow and Amstel have seen over 50% year-on-year growth - Snow Beer Pure Draft experienced a slight single-digit decline in sales year-on-year [1] Sales Performance by Region - The company highlighted strong sales momentum in Guangdong, particularly around the Shenzhen area - It is expected that East China and South China will become key drivers of sales growth in 2025 [1] Sales Performance by Channel - The management noted that demand in the ready-to-drink channel remains weak, although there was a slight improvement in some dining markets in East and South China in May - The company has gained some market share in the nightlife channel - The proportion of ready-to-drink channel sales remains stable, consistent with the end of 2024 levels, at approximately 38-39% [1] Capital Expenditure Plans - Due to strong Heineken sales, the company plans to expand Heineken production capacity in Fujian - In 2025, further investments are planned in maintenance, production line transformation, and the white liquor business - Future capital expenditures are expected to gradually decrease [2] Financial Assumptions - The report uses a discounted cash flow method with a weighted average cost of capital (WACC) of 11.3%, derived from a 3% risk-free rate and a 9.1% risk premium, and a terminal growth rate of 3% [2]

Investment Rating - The report maintains an "Outperform" rating for Pop Mart (09992) and raises the target price from HKD 256 to HKD 288, an increase of 12.5% [1] Core Insights - Pop Mart is expected to sustain growth with upcoming product launches and is rapidly increasing production to meet rising demand [1] - The company has strong intellectual property enforcement capabilities, which supports its valuation based on a 47% compound annual growth rate in earnings [1] - With robust operational and commercialization capabilities, smooth overseas expansion, and a comprehensive distribution network, Pop Mart remains a preferred choice in the industry [1]

Investment Rating - The report maintains a "Buy" rating for BYD Company Limited (1211 HK) with a target price of HKD 167.75, indicating a potential upside of 23.7% from the current closing price of HKD 135.60 [1][10]. Core Insights - The report highlights strong sales performance in May, with BYD selling a total of 382,476 vehicles, representing a year-on-year increase of 5.3% and a month-on-month increase of 1.2%. The sales of new energy passenger vehicles reached 376,930 units, up 14.1% year-on-year [7]. - BYD continues to lead the global new energy vehicle market, with a significant advantage over competitors, despite a slight decrease in market share in mainland China [7]. - The report emphasizes the robust performance of BYD's core sales networks, with the Dynasty and Ocean series contributing significantly to overall sales [7]. - High-end brands such as Tengshi and Fangchengbao have shown remarkable growth, with Tengshi's sales increasing by 29.3% year-on-year [7]. - Export sales reached a record high, with overseas sales of new energy vehicles totaling 89,047 units, a year-on-year increase of 133.6%, contributing to 23% of total sales [7]. - The report projects continued growth for BYD, driven by its competitive advantages in scale, technology, and brand, alongside an expanding high-end brand matrix and overseas production capacity [7]. Financial Overview - Revenue projections for BYD are as follows: RMB 602,315 million in 2023, RMB 777,102 million in 2024, and expected to reach RMB 977,249 million in 2025, reflecting a year-on-year growth of 42.0% and 29.0% respectively [3][11]. - Net profit is projected to grow from RMB 30,041 million in 2023 to RMB 40,254 million in 2024, and further to RMB 52,460 million in 2025, indicating a significant year-on-year increase of 80.7% and 34.0% respectively [3][11]. - The earnings per share (EPS) are expected to rise from RMB 3.30 in 2023 to RMB 4.42 in 2024, and RMB 5.75 in 2025, showcasing a strong growth trajectory [3][11]. - The price-to-earnings (P/E) ratio is projected to decrease from 37.7 in 2023 to 21.6 in 2025, indicating improving valuation metrics as earnings grow [3][11]. Market Position - BYD's market capitalization stands at approximately HKD 1,683,750.78 million, with a year-to-date price change of 52.59% [6]. - The stock has shown resilience with a 52-week high of HKD 155.07 and a low of HKD 69.20, reflecting strong investor interest and market confidence [6].

Investment Rating - The report maintains a "Buy" rating for BYD Company Limited (1211 HK) with a target price of HKD 167.75, indicating a potential upside of 23.7% from the current closing price of HKD 135.60 [1][10]. Core Insights - The report highlights strong sales performance in May, with BYD selling a total of 382,476 vehicles, representing a year-on-year increase of 5.3% and a month-on-month increase of 1.2%. The sales of new energy passenger vehicles reached 376,930 units, up 14.1% year-on-year [7]. - BYD continues to lead the global new energy vehicle market, with a significant advantage over competitors, despite a slight decrease in market share in mainland China [7]. - The report emphasizes the robust performance of BYD's core sales networks, with the Dynasty and Ocean series contributing significantly to overall sales [7]. - High-end brands such as Tengshi and Fangchengbao have shown remarkable growth, with Tengshi's sales increasing by 29.3% year-on-year [7]. - Export sales reached a record high, with overseas sales of new energy vehicles totaling 89,047 units, a year-on-year increase of 133.6%, driven by expansion in Southeast Asia, Europe, and South America [7]. - The report projects continued growth for BYD, supported by its competitive advantages in scale, technology, and brand, as well as the expansion of its high-end brand matrix and overseas production capacity [7]. Financial Overview - Revenue projections for BYD are as follows: RMB 602,315 million in 2023, RMB 777,102 million in 2024, and expected to reach RMB 977,249 million in 2025, reflecting a year-on-year growth of 42.0% in 2023 and 29.0% in 2024 [3][11]. - Net profit is projected to grow from RMB 30,041 million in 2023 to RMB 40,254 million in 2024, and further to RMB 52,460 million in 2025, indicating a significant year-on-year growth of 80.7% in 2023 [3][11]. - The report provides a detailed financial outlook, including earnings per share (EPS) expected to rise from RMB 3.30 in 2023 to RMB 5.75 in 2025, with a corresponding decrease in price-to-earnings (P/E) ratio from 37.7 in 2023 to 21.6 in 2025 [3][11].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [10][12]. Core Views - The company is a leader in the intra-Asian container shipping market, which has seen demand growth outpace the industry average in recent years. The company benefits from a high-frequency, high-density sea-land integrated operation model and a low-cost strategy, with a strong focus on shareholder returns [3][9][10]. Summary by Sections Introduction: Capitalizing on Southeast Asia - The report emphasizes the increasing market expectations for the company amid external uncertainties, particularly regarding tariffs. It aims to address whether the intra-Asian container shipping market is favorable and if the company is a good investment [6][16]. Company Overview - The company specializes in the intra-Asian container shipping market, providing comprehensive shipping and logistics services. It is controlled by Yang Shaopeng, who holds a 41.25% stake through a family trust. The management team has extensive experience in the shipping industry, with core members having been with the company for over 20 years [6][21][27]. Market Demand: Long-term Benefits from Industrial Transfer - The intra-Asian container shipping market, encompassing China, Japan, South Korea, and Southeast Asia, has maintained a growth rate exceeding the industry average. In 2024, this market is expected to account for approximately 31% of global container shipping volume [7][30]. Market Supply: Service Differentiation and Capacity Tightening - The market primarily consists of feeder vessels under 3,000 TEU, which dominate due to shorter routes and varying port infrastructure. The supply pressure for feeder vessels is expected to remain low, with growth rates projected at 0.6% and -3.0% for 2025 and 2026, respectively [8][59]. Competitive Advantages: Integrated Sea-Land Operations and Low-Cost Strategy - The company's resilience is highlighted, particularly during industry downturns. Its core competencies include a high-frequency, high-density operational model and a low-cost strategy. The fleet consists of 118 vessels, with 104 owned, and an average vessel size of 1,500-1,600 TEU, which enhances operational flexibility and management efficiency [9][10][56]. Investment Recommendations - Projected net profits for 2025-2027 are estimated at $1.094 billion, $876 million, and $824 million, respectively, with corresponding P/E ratios of 8.9, 11.1, and 11.8. The dividend payout ratio is expected to be around 70%, resulting in dividend yields of 7.9%, 6.3%, and 6.0% [10][12].